Biojet has completed the consept study (FEL-2)

The consept study (FEL-2) of Biojet's technological platform has now been completed with satisfactory results regarding technical maturity, operational robustness, total yield/throughput and economical parameters. Biojet is proceeding with internal processes and seeking investors for the next project phase. (FEL-3)

‍